Skip to content
Open access

Viral PDZ target sequences are not inherently more promiscuous than those derived from endogenous target proteins

Aug 2026 · Protein Science · Vol 35 · 0 citations · 79 references
Medicine

TL;DR

The data support previously reported sequence hotspots, whereby certain PBMs are recognized by large numbers of PDZ domains, likely due to a combination of widely favorable modulator residues, and support previously reported sequence hotspots.

Abstract

PDZ domains are one of the largest families of short linear motif (or peptide) binding domains in the human proteome. These scaffolding domains are important in signaling and trafficking pathways, such as in the formation of tight junctions or in the postsynaptic density of neurons. PDZ domains are also targeted by several pathogenic viral proteins, including human papillomavirus (HPV), influenza, hepatitis, rabies, coronaviruses, among others. Previously, we investigated the specificity determinants of modulator, or non‐motif, residues for two PDZ binding motifs (or PBMs) from the cystic fibrosis transmembrane conductance regulator (CFTR) and HPV16 E6 proteins to better understand differences in relative promiscuity between these similar sequences. To test whether viral PDZ‐binding motifs are inherently more promiscuous than endogenous targets, we measured binding affinities for 7 endogenous and 7 viral PBMs across 8 well‐studied Class I PDZ domains. Fluorescence anisotropy assays revealed no significant difference in relative binding affinities between viral and endogenous PBMs, indicating that viral versus endogenous origin alone does not explain PBM promiscuity. Our results were consistent with available data from high throughput holdup assays. Taken together, our data support previously reported sequence hotspots, whereby certain PBMs are recognized by large numbers of PDZ domains, likely due to a combination of widely favorable modulator residues.

Read PDF

Similar papers

Open access Aug 2026

SARS-CoV-2 Orf3a protein interaction mapping using unnatural amino acid incorporation

It is demonstrated that genetically encoded, site-specific photo-crosslinking enables selective capture of transient interactions that are often missed by nonspecific 254 nm UV crosslinking approaches and highlights Orf3a as a multifunctional protein that engages diverse host pathways.

Eryn Lundrigan, Noreen Ahmed, J. P. Pezacki · 0 citations
Open access Aug 2026

Peptide tiling across viral proteomes identifies modular regulators of stress-induced cell death

A pooled peptide tiling approach was applied to systematically identify compact viral protein regions that alter cell death and support a model in which viral proteins encode modular host-regulatory functions and establish peptide tiling as a scalable framework for functional annotation across viral proteomes.

Jaice T Rottenberg, Ezra Taub, Sean Cottrell et al. · 0 citations
Jul 2026

Characterizing Host-Viral Interaction Interfaces for Insights into Viral Transmission and Infections 2257274

The comprehensive 3D viral interactomes provide a rich resource for exploring viral adaptation, immune evasion, and pathogenesis mechanisms, empowering researchers to generate testable hypotheses and ultimately accelerate the discovery of novel therapeutic targets and intervention strategies.

Priyamvada Guha Roy, Le Li, Zi-Zhao Zhang et al. · 0 citations
Open access Aug 2026

Sequence‐encoded determinants drive distinct early aggregation pathways and different structural outcomes in PNT1 fibrils across Henipavirus members

Findings indicate that the sequence context beyond a conserved amyloidogenic core governs the aggregation landscape of Henipavirus P, V, and W proteins, shedding light on the molecular grammar underlying viral protein fibrillation with potential implications for viral pathogenicity.

Harshita Sawdekar, Julien Mignon, Frank Gondelaud et al. · 0 citations
Open access Aug 2026

Nanobodies targeting SARS-CoV-2 papain-like protease exert dual antiviral and anti-inflammatory effects

It is demonstrated that nanobodies targeting the PLpro/ISG15 interface can achieve synergistic antiviral and immunomodulatory effects, providing a proof-of-concept for a novel therapeutic approach to combat SARS-CoV-2 and potentially other emerging coronaviruses.

Guo-Long Liu, Jian-Tao Chen, Fang Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.